Advances in Tumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing

Gain insights into the latest advances in NTRK fusion testing and recent advances in tumor-agnostic TRK inhibition through expert-guided discussion.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bayer Healthcare Pharma

Genentech TEXT Only